These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19187071)

  • 1. Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions.
    Kotler DP
    Liver Int; 2009 Mar; 29 Suppl 2():38-46. PubMed ID: 19187071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Resistance and the cardiometabolic syndrome in HIV infection.
    Bevilacqua M; Dominguez LJ; Barbagallo M
    J Cardiometab Syndr; 2009; 4(1):40-3. PubMed ID: 19245515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidaemia and cardiovascular risk in HIV infection.
    Kulasekaram R; Peters BS; Wierzbicki AS
    Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic side effects of antiretroviral therapy].
    van der Valk M; Reiss P
    Ned Tijdschr Geneeskd; 2008 May; 152(22):1260-4. PubMed ID: 18590059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of common chronic metabolic complications in HIV-infected patients.
    Bader MS; Kelly DV
    Postgrad Med; 2008 Nov; 120(4):17-27. PubMed ID: 19020362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-associated lipodystrophy: from fat injury to premature aging.
    Caron-Debarle M; Lagathu C; Boccara F; Vigouroux C; Capeau J
    Trends Mol Med; 2010 May; 16(5):218-29. PubMed ID: 20400373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difficulties in understanding the metabolic complications of acquired immune deficiency syndrome.
    Grunfeld C; Tien P
    Clin Infect Dis; 2003; 37 Suppl 2():S43-6. PubMed ID: 12942373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection.
    Samaras K
    J Antimicrob Chemother; 2008 Feb; 61(2):238-45. PubMed ID: 18070830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic disorders and chronic viral disease: the case of HIV and HCV.
    Slama L; Le Camus C; Serfaty L; Pialoux G; Capeau J; Gharakhanian S
    Diabetes Metab; 2009 Feb; 35(1):1-11. PubMed ID: 19046914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible posterior leukoencephalopathy syndrome in 2 HIV-infected patients receiving antiretroviral therapy.
    Ridolfo AL; Resta F; Milazzo L; Caramma I; Matacena G; Antinori S; Galli M
    Clin Infect Dis; 2008 Jan; 46(2):e19-22. PubMed ID: 18171242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Co-infection with HIV and viral hepatitis C].
    Pialoux G
    Med Mal Infect; 2006 Jul; 36 Suppl 2():S218-23. PubMed ID: 17076000
    [No Abstract]   [Full Text] [Related]  

  • 13. Human immunodeficiency virus and atherosclerosis.
    Farrugia PM; Lucariello R; Coppola JT
    Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral induced adverse drug reactions in Iranian human immunodeficiency virus positive patients.
    Khalili H; Dashti-Khavidaki S; Mohraz M; Etghani A; Almasi F
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):848-57. PubMed ID: 19551698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection: molecular pathways to metabolic syndrome.
    Sheikh MY; Choi J; Qadri I; Friedman JE; Sanyal AJ
    Hepatology; 2008 Jun; 47(6):2127-33. PubMed ID: 18446789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interference among antiretroviral, anti-HCV, and immunosuppressive treatments].
    Peytavin G
    Med Mal Infect; 2004 Nov; 34 Spec No 2():20-1. PubMed ID: 15801535
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease- and treatment-related predictors of hepatic mitochondrial dysfunction in chronic HIV infection assessed by non-invasive (13)C-methionine breath test diagnostic.
    Banasch M; Knyhala K; Kollar S; Serova K; Potthoff A; Schlottmann R; Schmidt WE; Brockmeyer NH; Goetze O
    Eur J Med Res; 2008 Sep; 13(9):401-8. PubMed ID: 18948231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of facial lipoatrophy in HIV-infected patients.
    Prescrire Int; 2008 Aug; 17(96):170. PubMed ID: 19492497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.